Veeco Instrs Inc Del SEC Filings

Form 144 notice for proposed sale of securities by a party associated with Veeco Instruments, Inc. The filing reports an intended sale of 4,046 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $105,196.00, to be offered on or about 09/15/2025 on the NASDAQ. The filing states 60,161,823 shares outstanding for the class. The shares were acquired by the seller via restricted stock vesting on 09/01/2021 (818 shares) and 09/14/2021 (3,228 shares) and were paid as compensation. The filing reports Nothing to Report for sales during the past three months. Several filer and issuer identification fields in the form are blank in the provided content.

Insider sale and correction: William John Miller, identified as both CEO and a director of Veeco Instruments Inc (VECO), reported a disposition of 25,000 shares of Veeco common stock at $25.00 per share, leaving him with 539,543 shares beneficially owned after the transaction. The Form 4/A amends a prior filing to correct the number of shares shown in Box 5; the amendment states no additional shares were sold beyond those disclosed in the original report. The filing also indicates the transaction was made pursuant to a written plan intended to satisfy Rule 10b5-1 affirmative defense conditions, which typically documents pre-arranged sales.

Veeco Instruments insider transaction: William John Miller, identified as the company's CEO and a director, reported a sale of 25,000 shares of Veeco Instruments Inc. (VECO) on 09/09/2025 at a price of $25 per share. After the reported sale, Mr. Miller beneficially owned 470,671 shares. The filing indicates the transaction was made pursuant to a Rule 10b5-1 trading plan. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Veeco Instruments Inc. (VECO) filed a Form 144 reporting a proposed sale of 25,000 shares of common stock through Wells Fargo Clearing Services with an aggregate market value of $624,493.00. The filing lists the approximate outstanding shares as 60,161,823 and an intended sale date of 09/09/2025 on Nasdaq.

The shares to be sold were acquired in 2024 as grants: 7,138 shares on 03/13/2024, 6,787 on 03/12/2024 and 11,075 on 03/18/2024. The filer indicates no sales in the past three months and certifies no undisclosed material adverse information. This is a routine Rule 144 notice describing a proposed sale by a person whose holdings were obtained via issuer grants.

Manulife and its investment-management subsidiaries reported beneficial ownership stakes in Veeco Instruments common stock. Manulife Investment Management (US) LLC holds 3,195,268 shares, representing 5.48% of the 58,292,152 shares outstanding cited in the filing. Manulife Investment Management Limited holds 19,763 shares (about 0.03%), and through its parent-subsidiary relationship, Manulife Financial Corporation may be deemed to beneficially own these holdings.

The Schedule 13G/A clarifies voting and dispositive powers: the reporting entities state sole voting and sole dispositive power over the shares listed. The filing is a disclosure of institutional ownership crossing the 5% threshold by MIM (US) and documents the corporate and regulatory identities of the reporting persons.